Association Between Matrix Metalloproteinase-2 Gene Polymorphism rs243865 and Susceptibility to Cataract Development

NCT05670834 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2024-07-23

No results posted yet for this study

Summary

The primary aim of this study is to investigate the potential association between MMP-2 gene polymorphism and susceptibility to cataract development in Egyptian patients. Furthermore, this study aims to compare between cataract patients and healthy controls by measuring the serum IL-6 concentration to evaluate its relationship with disease.

Conditions

  • Cataract

Interventions

GENETIC

genotyping assay by real-time PCR

genotyping assay of MMP-2 gene with the real-time polymerase chain reaction

DIAGNOSTIC_TEST

ELISA

. IL-6 level in serum will be analyzed by ELISA assay kit.

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-01
Primary Completion
2024-01-30
Completion
2024-04-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05670834 on ClinicalTrials.gov